Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5114504

[Cl-].[Cl-].[Pd+2].c1ccc(PCCPc2ccccc2)cc1.c1ccc(PCCPc2ccccc2)cc1

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
CA12 O43570 1/20 0.33
GLA P06280 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA7 P43166 1/20 0.33
CALM1 P0DP23 1/20 0.32
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11804962 0.94 CA1 (0.33) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL7588877 0.94 CA1 (0.33) CA1CA2CA9CA12GLA
Bromide SCHEMBL10527789 0.94 CA1 (0.33) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL22129660 0.94 CA1 (0.33) CA1CA2CA9CA12GLA
SCHEMBL45645 0.94 CA1 (0.37) CA1CA2CA9CA12GLA
SCHEMBL27501489 0.91 CA1 (0.35) CA1CA2CA9CA12GLA
SCHEMBL27556640 0.91 CA1 (0.35) CA1CA2CA9CA12GLA
SCHEMBL11796269 0.91 CA1 (0.35) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL5107617 0.89 CA1 (0.30) CA1CA2CA9CA12GLA
Hydrochloric Acid SCHEMBL5107414 0.89 CA1 (0.30) CA1CA2CA9CA12GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7355053-B2 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2008-04-08 US disclosed
US-20060019831-A1 1-phenylpyrrolidine-2-one-3-carboxamides BASF AKTIENGESELLSCHAFT (DE) 2006-01-26 US disclosed
EP-0652216-B1 Substituted Pyridyl salicylic aldehyde and salicylic acid derivatives, methods for preparing them and their use as herbicides BASF AG (DE) 2001-02-28 EP disclosed
US-6169184-B1 REACTING SUBSTITUTED PYRIDINE WITH SPECIFIED ARYL COMPOUND BASF AKTIENGESELLSCHAFT (DE) 2001-01-02 US disclosed
EP-0657441-B1 Cyclic acetals, processes for their production and conversion into herbicides BASF AG (DE) 2000-03-01 EP disclosed
US-5783521-A Substituted pyridylsalicylaldehyde or -salicylic acid derivatives, their preparation and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 1998-07-21 US disclosed
US-5777118-A PLANT SAFENING AGENTS BASF AKTIENGESELLSCHAFT (DE) 1998-07-07 US disclosed
US-5627136-A HERBICIDES, ANTIGROWTH REGULATORS AND PLANT GROWTH REGULATORS BASF AKTIENGESELLSCHAFT (DE) 1997-05-06 US disclosed
WO-1997012883-A1 INTERMEDIATES AND PROCESS FOR THE PREPARATION OF SUBSTITUTED SALICYLIC ACID DERIVATIVES AS PLANT PROTECTIVE AGENTS BASF AKTIENGESELLSCHAFT (DE) 1997-04-10 WO disclosed
US-5569640-A HERBICIDE BASF AKTIENGESELLSCHAFT (DE) 1996-10-29 US disclosed
EP-0657441-A2 Cyclic acetals, processes for their production and conversion into herbicides BASF Aktiengesellschaft (DE) 1995-06-14 EP disclosed
EP-0656357-A1 Substituted pyridyl-n-oxide salicylic aldehyde and salicylic acid derivatives, methods for preparing them and their use as herbicides BASF Aktiengesellschaft (DE) 1995-06-07 EP disclosed
EP-0652216-A2 Substituted Pyridyl salicylic aldehyde and salicylic acid derivatives, methods for preparing them and their use as herbicides BASF Aktiengesellschaft (DE) 1995-05-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019831-A1 1-phenylpyrrolidine-2-one-3-carboxamides RXFP1, REN, NPY1R CA1 95/4885CA2 4/4885CA9 528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.